BioNTech
-
Pfizer/BioNTech say COVID-19 vaccine likely to prevent asymptomatic infection
The latest analysis of the Israeli data shows the vaccine was 97 per cent effective in preventing symptomatic disease Pfizer…
Read More » -
Pfizer/BioNTech COVID-19 vaccine neutralises Brazil variant in lab study
Pfizer believes its current vaccine is highly likely to still protect against the South African variant The COVID-19 vaccine from…
Read More » -
US FDA gearing up for rapid review of potential COVID-19 booster shots amid rise of virus variants
The agency plans to issue a proposal on the process for public comment in a few weeks The US Food…
Read More » -
WHO emergency COVID-19 vaccine listing aims to lift access in poor countries
The United Nations health agency said it will work with regional partners to tell national health authorities about the two-dose…
Read More » -
Pfizer not yet ready to release COVID-19 vaccine data
Pfizer hopes to be the first US drugmaker to unveil successful data from a late-stage COVID-19 vaccine trial, ahead of…
Read More » -
Pfizer to enroll kids as young as 12 in COVID-19 vaccine study
Pfizer will enroll participants as young as 12 in its large, late-stage COVID-19 vaccine trial to understand how it works…
Read More »